U heeft gezocht op: HARTMANN+PAUL

231 results were found

Verfijn resultaten Sorteren bij

Sort Results

List view Easy View (new)

Vergelijk(0) Clear

Rate These Search Results

Microcentrifuge tubes

Catalogus nummer: (BOET02.013.0100)

Leverancier: BOETTGER PAUL

Omschrijving: Made from selected high-quality and biologically inert polypropylene.

UOM: 1 * 1.000 ST

Sale

N/A Each

Human Recombinant IFN-alpha 2B

Leverancier: STEMCELL Technologies

Omschrijving: Interferon-alpha (IFN-α) is a type I interferon, produced by virus infected cells, and is released as a soluble factor to initiate antiviral responses (Isaacs and Lindenmann). IFN-α2 is the most potent IFN-α used in fundamental research and in most clinical applications. The best known IFN-α2 subvariants, 2A and 2B, differ by only one or two amino acids at positions 23 and/or 34 of the mature protein (von Gabain et al.). Type I IFNs exert potent antitumor activity by increasing the cytotoxic activity of NK and T cells, as well as inhibiting the proliferation of cancer cells (Paul et al.). Additionally, it has been shown that proinflammatory IFN-α modulates the function of B cells in patients with systemic lupus erythematosus (Chang et al.) and pegylated form of IFN-α 2A and 2B has implications in the treatment of Hepatitis C (Foster et al.).

Transport container with screw cap

Leverancier: BOETTGER PAUL

Omschrijving: Made of PP, translucent. Mailing containers for medical and biohazard samples.

Vials for cell counters

Catalogus nummer: (BOET02.901.2100)

Leverancier: BOETTGER PAUL

Omschrijving: Optically clear vials with parallel surfaces, free of dust or particles.

UOM: 1 * 250 ST

Sale

N/A Each

Human Recombinant IFN-alpha 2A

Leverancier: STEMCELL Technologies

Omschrijving: Interferon-alpha (IFN-α) is a type I interferon, produced by virus-infected cells, and is released as a soluble factor to initiate antiviral responses (Isaacs and Lindenmann). IFN-α2 is the most potent IFN-α used in fundamental research and in most clinical applications. The best-known IFN-α2 subvariants, 2A and 2B, differ by only one or two amino acids at positions 23 and/or 34 of the mature protein (von Gabain et al.). Type I IFNs exert potent antitumor activity by increasing the cytotoxic activity of NK and T cells, as well as by inhibiting the proliferation of cancer cells (Paul et al.). Additionally, it has been shown that proinflammatory IFN-α modulates the function of B cells in patients with systemic lupus erythematosus (Chang et al.), and pegylated forms of IFN-alpha 2A and 2B have implications in the treatment of hepatitis C (Foster et al.).